Protocol S1900K, "A Randomized Phase II Study of Tepotinib with or without Ramucirumab in Participants with MET Exon 14 Skipping Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Sub-Study)"
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/cancer.jpg)
Details
Age
Adult
Locations
Greeley Campus
Harmony Campus
Medical Center of the Rockies
Memorial Hospital Central
Memorial Hospital North
Poudre Valley Hospital
University of Colorado Hospital
Principal Investigator
![Photograph of Tejas Patil](https://som.ucdenver.edu/FIMS/Content/faculty/24489/CU-Doctors-24489.jpg)
Tejas Patil
Study ID
Protocol Number: 24-0486
More information available at ClinicalTrials.gov: NCT06031688
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers